This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,760.70, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 24, 2024. The contract was awarded on December 23, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract supports the DLA's Troop Support Medical program, which provides pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/30/25, 12:47 AM